Russia taps nanotech for drug production

Rusnano, the Russia Corporation of Nanotechnologies, is working to develop nanodrugs for cancer treatment. Its goal: Production facilities by 2014 for cancer-fighters with systems of targeted delivery--liposomes, immunoliposomes, and monoclonal antibodies. Release

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.